Table 2 Clinical findings of the observation group of combined hamartomas of the retina and retinal pigment epithelium (CHRRPE) patients (n = 9).
Patient No. / Age, y/ Sex | Tumor location | Tumor basal dimension, mm | Tumor ultrasound thickness, mm | PVD | ERM | Intraretinal hemorrhage | Intraretinal Exudation | Subretinal fluid | Pigmentation | CMT, μm | 3.0 mm ETDRS grid , μm | BCVA, logMAR | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nas | Tem | Sup | Inf | ||||||||||||
1 / 17 / M | Macular | 5.60 | 1.10 | No | Yes | No | No | No | Yes | 257 | 352 | 312 | 319 | 294 | 0.398 |
2 / 34 / F | Peripapillary | 6.00 | 1.87 | No | Yes | No | No | No | Yes | 784 | 996 | 623 | 860 | 517 | 0.301 |
3 / 78 / M | Peripapillary | 4.15 | 1.19 | No | Yes | No | Yes | Yes | Yes | 477 | 471 | 432 | 405 | 413 | 0.398 |
4 / 25 / M | Peripapillary | 6.90 | 1.03 | No | Yes | No | No | No | No | 430 | 575 | 401 | 438 | 400 | 0.045 |
5 / 62 / F | Peripapillary | 2.23 | 1.19 | No | Yes | No | No | No | No | 333 | 396 | 333 | 343 | 328 | 0.155 |
6 / 25 / F | Peripapillary | 2.20 | 1.14 | No | Yes | No | No | No | Yes | 247 | 325 | 311 | 328 | 318 | 0.000 |
7 / 27 / M | Peripapillary | 6.68 | 1.50 | No | Yes | No | No | No | Yes | 428 | 602 | 373 | 433 | 423 | 0.097 |
8 / 43 / M | Peripapillary | 5.00 | 1.00 | No | Yes | No | No | No | Yes | 470 | 579 | 438 | 559 | 455 | 0.000 |
9 / 33 / M | Peripapillary | 3.03 | 0.90 | No | Yes | No | No | No | No | 287 | 382 | 343 | 374 | 352 | 0.000 |
38 ± 20 y / M = 6 (66.7%) F = 3 (33.3%) | Peripapillary = 8 (88.9%) Macular = 1 (11.1%) | 4.64 ± 1.83 | 1.21 ± 0.30 | 0 (0%) | 9 (100%) | 0 (0%) | 1 (11.1%) | 1 (11.1%) | 6 (66.7%) | 413 ± 166 | 520 ± 207 | 396 ± 98 | 451 ± 170 | 389 ± 72 | 0.155 ± 0.168 |
